{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:30:13Z","timestamp":1770881413619,"version":"3.50.1"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4188","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T18:05:40Z","timestamp":1430417140000},"page":"1131-1134","source":"Crossref","is-referenced-by-count":16,"title":["Acute Kidney Injury due to Renal Sarcoidosis during Etanercept Therapy: A Case Report and Literature Review"],"prefix":"10.2169","volume":"54","author":[{"given":"Mitsuhiro","family":"Akiyama","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironari","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Hunninghake GW, Costabel U, Ando M, et al. ATS\/ERS\/WASOG statement on sarcoidosis: American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16: 149-173, 1999."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Doty J, Mazur J, Judson M. Treatment of sarcoidosis with infliximab. Chest 127: 1064-1071, 2005.","DOI":"10.1378\/chest.127.3.1064"},{"key":"3","unstructured":"3. Vigne C, Tebib JG, Pacheco Y, Coury F. Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy. Joint Bone Spine 80: 104-107, 2013."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Perez R, Perez M, Ramos M. Biologics-induced autoimmune diseases. Curr Opin Rheumatol 25: 56-64, 2013.","DOI":"10.1097\/BOR.0b013e32835b1366"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Daien CI, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 case. Rheumatology 48: 883-886, 2009.","DOI":"10.1093\/rheumatology\/kep046"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Massara A, Cavazzini L, La R, Trotta F. Sarcoidosis appearing during anti-tumor necrosis alpha therapy: a new \"class effect\" paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum 39: 313-319, 2010.","DOI":"10.1016\/j.semarthrit.2008.11.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Utz JP, Limper AH, Kalra S, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124: 177-185, 2003.","DOI":"10.1378\/chest.124.1.177"},{"key":"8","unstructured":"8. Mah&eacute;vas M, Lescure FX, Boffa JJ, et al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 88: 98-106, 2009."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Durel CA, Feurer E, Pialat JB, Berthoux E, Chapurlat RD, Confavreux CB. Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurol 13: 212, 2013.","DOI":"10.1186\/1471-2377-13-212"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Unterstell N, Bressan AL, Serpa LA, Fonseca e Castro PP, Gripp AC. Systemic sarcoidosis induced by etanercept: first Brazilian case report. An Bras Dermatol 88: 197-199, 2013.","DOI":"10.1590\/abd1806-4841.20132588"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Dragnev D, Barr D, Kulshrestha M, Shanmugalingam S. Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab. BMJ Case Rep 4: 2013, 2013.","DOI":"10.1136\/bcr-2013-200552"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vigne C, Tebib JG, Pacheco Y, Coury F. Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy. Joint Bone Spine 80: 104-107, 2013.","DOI":"10.1016\/j.jbspin.2012.05.001"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T06:41:06Z","timestamp":1498200066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/9\/54_54.4188\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4188","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}